216 related articles for article (PubMed ID: 28329774)
1. [Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients].
Wawryka J; Barg E
Pediatr Endocrinol Diabetes Metab; 2016; 22(2):60-65. PubMed ID: 28329774
[TBL] [Abstract][Full Text] [Related]
2. Proposed Tandem Effect of Physical Activity and Sirtuin 1 and 3 Activation in Regulating Glucose Homeostasis.
Pacifici F; Di Cola D; Pastore D; Abete P; Guadagni F; Donadel G; Bellia A; Esposito E; Salimei C; Sinibaldi Salimei P; Ricordi C; Lauro D; Della-Morte D
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557786
[TBL] [Abstract][Full Text] [Related]
3. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.
Song YS; Lee SK; Jang YJ; Park HS; Kim JH; Lee YJ; Heo YS
Diabetes Res Clin Pract; 2013 Sep; 101(3):341-8. PubMed ID: 23876548
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
Bhalla S; Gordon LI
Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
[TBL] [Abstract][Full Text] [Related]
5. Pyrroloquinoline quinone increases the expression and activity of Sirt1 and -3 genes in HepG2 cells.
Zhang J; Meruvu S; Bedi YS; Chau J; Arguelles A; Rucker R; Choudhury M
Nutr Res; 2015 Sep; 35(9):844-9. PubMed ID: 26275361
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of SIRT1 in fatty liver diseases.
Ding RB; Bao J; Deng CX
Int J Biol Sci; 2017; 13(7):852-867. PubMed ID: 28808418
[TBL] [Abstract][Full Text] [Related]
7. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity.
Moschen AR; Wieser V; Gerner RR; Bichler A; Enrich B; Moser P; Ebenbichler CF; Kaser S; Tilg H
J Hepatol; 2013 Dec; 59(6):1315-22. PubMed ID: 23928404
[TBL] [Abstract][Full Text] [Related]
9. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells.
Kozako T; Aikawa A; Shoji T; Fujimoto T; Yoshimitsu M; Shirasawa S; Tanaka H; Honda S; Shimeno H; Arima N; Soeda S
Int J Cancer; 2012 Nov; 131(9):2044-55. PubMed ID: 22322739
[TBL] [Abstract][Full Text] [Related]
10. HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells.
Fang M; Fan Z; Tian W; Zhao Y; Li P; Xu H; Zhou B; Zhang L; Wu X; Xu Y
Biochim Biophys Acta; 2016 Feb; 1859(2):294-305. PubMed ID: 26619800
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes.
Chang E; Kim Y
Nutrition; 2016 Jun; 32(6):702-8. PubMed ID: 26899162
[TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of Sirtuin 1 in Cellular Metabolism, Diabetes Mellitus, Diabetic Kidney Disease and Hypertension.
Guclu A; Erdur FM; Turkmen K
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):131-9. PubMed ID: 26588494
[TBL] [Abstract][Full Text] [Related]
13. The role of SIRT1 in ocular aging.
Mimura T; Kaji Y; Noma H; Funatsu H; Okamoto S
Exp Eye Res; 2013 Nov; 116():17-26. PubMed ID: 23892278
[TBL] [Abstract][Full Text] [Related]
14. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
[TBL] [Abstract][Full Text] [Related]
15. State of the art - sirtuin 1 in kidney pathology - clinical relevance.
Bazyluk A; Malyszko J; Hryszko T; Zbroch E
Adv Med Sci; 2019 Sep; 64(2):356-364. PubMed ID: 31125865
[TBL] [Abstract][Full Text] [Related]
16. SIRT1/SREBPs-mediated regulation of lipid metabolism.
Shen S; Shen M; Kuang L; Yang K; Wu S; Liu X; Wang Y; Wang Y
Pharmacol Res; 2024 Jan; 199():107037. PubMed ID: 38070792
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA-9-3p reduces lipid accumulation in HepG2 cells by targeting the expression of sirtuin type 1.
Sun YN; Li S; Zhou YT; Liu J; Tian LB; Zhen YF; Fang H
Mol Med Rep; 2015 Nov; 12(5):7742-8. PubMed ID: 26459099
[TBL] [Abstract][Full Text] [Related]
18. A Review on SIRtuins in Diabetes.
Aditya R; Kiran AR; Varma DS; Vemuri R; Gundamaraju R
Curr Pharm Des; 2017; 23(16):2299-2307. PubMed ID: 28128062
[TBL] [Abstract][Full Text] [Related]
19. Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.
Pulla VK; Battu MB; Alvala M; Sriram D; Yogeeswari P
Expert Opin Ther Targets; 2012 Aug; 16(8):819-32. PubMed ID: 22762724
[TBL] [Abstract][Full Text] [Related]
20. Metabolic benefits from Sirt1 and Sirt1 activators.
Chaudhary N; Pfluger PT
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):431-7. PubMed ID: 19474719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
